Foscarnet Tillomed for CMV retinitis in immunocompromised
Quick answer: Foscarnet Tillomed is used for CMV retinitis in immunocompromised as part of a antiviral (pyrophosphate analog) treatment regimen. Inhibits viral DNA polymerase by blocking the pyrophosphate binding site without requiring intracellular activation The specific dosing for CMV retinitis in immunocompromised is determined by your prescriber based on individual factors.
Why is Foscarnet Tillomed used for CMV retinitis in immunocompromised?
Foscarnet Tillomed belongs to the Antiviral (pyrophosphate analog) class. Inhibits viral DNA polymerase by blocking the pyrophosphate binding site without requiring intracellular activation This action makes it useful for treating or managing CMV retinitis in immunocompromised in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Foscarnet Tillomed is the right choice for a specific patient depends on the type and severity of CMV retinitis in immunocompromised, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for CMV retinitis in immunocompromised
Common adult dosing range: 60 mg/kg IV every 8 hours (induction) or 90-120 mg/kg daily (maintenance). The actual dose for CMV retinitis in immunocompromised depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Foscarnet Tillomed medicine page.
What to expect
Foscarnet Tillomed treatment for CMV retinitis in immunocompromised typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on CMV retinitis in immunocompromised
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Foscarnet Tillomed is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Antiviral (pyrophosphate analog) for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Foscarnet Tillomed
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Foscarnet Tillomed full prescribing information · All Antiviral (pyrophosphate analog) alternatives
Frequently asked questions
How effective is Foscarnet Tillomed for CMV retinitis in immunocompromised?
Effectiveness varies by individual response, dose, and severity. Foscarnet Tillomed is one of several treatment options for CMV retinitis in immunocompromised, supported by clinical evidence within the antiviral (pyrophosphate analog) class. Discuss expected response with your prescriber.
How long do I need to take Foscarnet Tillomed for CMV retinitis in immunocompromised?
Treatment duration depends on the nature of CMV retinitis in immunocompromised — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Foscarnet Tillomed when used for CMV retinitis in immunocompromised?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Foscarnet Tillomed for CMV retinitis in immunocompromised?
Yes. Multiple medicines and non-drug options exist for CMV retinitis in immunocompromised. Alternatives within the antiviral (pyrophosphate analog) class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.